Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

C Karapetis, D Yip, K Virik, A Strickland, K Ryder, M Cowling, P Harper

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9ba079296dfd4fac839b9ba60657cfe6,

title = "Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site",

author = "C Karapetis and D Yip and K Virik and A Strickland and K Ryder and M Cowling and P Harper",

year = "2001",

language = "English",

volume = "18",

pages = "23--32",

journal = "Medical Oncology",

issn = "1357-0560",

publisher = "Humana Press",

number = "1",

}

TY - JOUR

T1 - Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

AU - Karapetis, C

AU - Yip, D

AU - Virik, K

AU - Strickland, A

AU - Ryder, K

AU - Cowling, M

AU - Harper, P

PY - 2001

Y1 - 2001

M3 - Article

SN - 1357-0560

VL - 18

SP - 23

EP - 32

JO - Medical Oncology

JF - Medical Oncology

IS - 1

ER -